Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
110Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-7.99M | $-0.20 |
| 2024 | $0.00 | $-11.12M | $-0.28 |
| 2023 | $0.00 | $-21.03M | $-0.54 |
| 2022 | $1.35M | $-33.28M | $-0.85 |
| 2021 | $1.35M | $-64.18M | $-1.64 |
Social Signal Score
Earnings
Typical surprise +90.7% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 14$-0.02 vs $-0.54beat
- Wed, May 13$-0.05 vs $-0.54beat
- Wed, Mar 25$-0.05 vs $-0.54beat
Estimates and results for BYSI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
BYSIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsglobenewswire.com·23h ago·Positive
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update ASCO 2026 Data Demonstrate Long-term Survival Benefit of Plinabulin/Docetaxel and Pembrolizumab in Metastatic NSCLC Following Progression on First-Line Immune Checkpoint Inhibitor (ICI) Therapy
View source ↗